Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER
Status:
Terminated
Trial end date:
2020-09-30
Target enrollment:
Participant gender:
Summary
This extended access study will assess the long-term safety and tolerability of bardoxolone
methyl in qualified patients with pulmonary hypertension (PH) who previously participated in
controlled clinical studies with bardoxolone methyl.